Navigation Links
Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott
Date:11/2/2011

ALLEGAN, Mich., Nov. 2, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for testosterone gel 1.0% and that it has notified Abbott Products Inc., the owner of the Reference Listed Drug of its filing. On October 31, 2011, Abbott filed suit against Perrigo in the United States District Court for the District of New Jersey, alleging patent infringement. This action formally initiates the process under the Hatch-Waxman Act. 

Androgel® 1.0% (testosterone gel 1.0%) is indicated to treat adult males who have low or no testosterone. Annual sales were approximately $900 million annually, as measured by Wolters Kluwer Health.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This filing is another example of our investment in new products and expansion of our extended topicals pipeline. As always, Perrigo is committed to making quality healthcare more affordable for our customers."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate t
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Perrigo Announces Launch of Generic Version of Elestat®
2. Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology
3. Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
4. Perrigo Company Announces Quarterly Dividend
5. Perrigo Expands Infant Formula Distribution in China With Founder Group
6. Perrigo Company Will Release First Quarter Fiscal 2012 Results On October 27, 2011
7. Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam
8. Perrigo to Host Analyst Day on October 5, 2011 at the TASE, Tel Aviv Stock Exchange in Tel Aviv, Israel
9. Perrigo to Host Analyst Day on September 27, 2011 at the NASDAQ MarketSite in Times Square
10. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
11. Perrigo Company Will Release Fourth Quarter Fiscal 2011 Results on August 16, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals announced ... KX2-361 at Roswell Park Cancer Institute. KX2-361 ... drug that has shown potent inhibitory activity against a ... that are resistant to Temozolomide (T98G), the most widely ... a well-established brain tumor mouse model, KX2-361 consistently clears ...
(Date:12/24/2014)... , Dec. 24, 2014  Conkwest, Inc., ... developing the proprietary Natural Killer (NK) cell-line platform, ... Dr. Patrick Soon-Shiong , NantWorks founder, physician ... definitive agreement to purchase approximately $48 million of ... with the investment, he will be named Co-Chairman ...
(Date:12/24/2014)... LONDON , December 24, 2014 ... to grow at an average rate of 8.1%. The ... volume. Hip, knee and spine surgeries are the common ... economies they have a lower penetration. Increased number of ... of composites. Non-metallic orthopedic devices have gained popularity in ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... recently enacted standard has replaced the Statement on Auditing ... Statement on Standards for Attestation Engagements No. 16 (SSAE ... service organizations to enforce a stronger set of controls ... http://photos.prnewswire.com/prnh/20080206/AQW030LOGO-b ) Rising Medical Solutions has taken ...
... BASIS Science, Inc., creators of the Basis™ B1 band, ... medical, social and gaming luminaries including Kevin Colleran, Charles and ... has hired Chris Verplaetse to join the company,s executive team ... to be launched later this year, the Basis B1 band ...
Cached Medicine Technology:Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 2Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 3Basis Announces Advisory Board Members from Medicine, Gaming and Social Networking 2Basis Announces Advisory Board Members from Medicine, Gaming and Social Networking 3
(Date:12/25/2014)... News) -- The risk of burns from fires and ... to be extra cautious, an expert says. "Between ... increase in patients coming in with burns," said Dr. ... Firefighters Burn Center of Stony Brook University Hospital in ... joy, but if not careful, could quickly turn tragic," ...
(Date:12/25/2014)... Dennis Thompson HealthDay ... Researchers could be closing in on a "fountain of youth" ... the health of older adults, a new study suggests. ... given a drug that targets a genetic signaling pathway linked ... Novartis report. The experimental medication, a version ...
(Date:12/25/2014)... 2014 “ SmileStix ” was featured on ... latest and coolest mobile applications on the iOS, Android, and ... of NewsWatch, conducted the app review and shared with viewers ... stickers. , The old saying goes, “A picture says a ... that can describe a single image, because each picture holds ...
(Date:12/25/2014)... Each year trauma accounts for approximately ... admissions across the nation (according to the Centers ... National Hospital Ambulatory Medical Care Survey collected data ... 2010. They estimated that there were between 3.5 and ... primary diagnosis of broken bone or fracture. , ...
(Date:12/24/2014)... (PRWEB) December 25, 2014 Over 700 ... to their local communities. That is 700 smiling little ... single gift. Additionally over $6000 in monetary donations was ... offset some of the expenses they incur through the ... drive were A Child's Haven , Shrine's Children's ...
Breaking Medicine News(10 mins):Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4Health News:AlignLife Donates Over 700 Toys This Year 2
... 5 It,s official...Curamin is the natural products ... Curamin, the number-one pain-relieving product, is slated to ... Vitamin Retailer magazine in its upcoming June ... best-selling products based on a nationwide survey of ...
... Platform makes it easy for healthcare professionals to perform full "Google" ... ... Lake Forest, IL (PRWEB) May 5, 2009 -- Scribe Healthcare Technologies, ... easy for healthcare providers to conduct full "Google" like searches for ...
... May 5 Increased public and private ... of medical insurance coverage and continued foreign ... growth within the Kenyan healthcare industry. The ... continued expansion as the government boosts the ...
... DDS of Raleigh Comprehensive and Cosmetic Dentistry is one of the ... for oral sedation dentistry. , ... Raleigh, NC (PRWEB) ... L. Williamson III and Associates, announced recently that the practice has ...
... PharmaTech (NYSE: WX ) today,announced that it ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ... WuXi PharmaTech, Mr. Zhou worked for eleven years at,General ... positions of increasing responsibility,in financial planning and analysis, enterprise ...
... - Revenue of $337 million declined 10.1 percent ... on U.S. hospital capital spending and foreign exchange- ... operations was $0.27 versus $0.26 in prior year, ... fully diluted share from continuing operations of $7.44 ...
Cached Medicine News:Health News:Curamin Voted Best New Natural Remedy in the Country 2Health News:Dictation, Transcription Workflow and Document Management Platform Aids Physicians In Searching For Swine Flu Symptoms 2Health News:Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan 2Health News:Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan 3Health News:Raleigh Comprehensive and Cosmetic Dentistry Earns Certification For Sedation Dentistry 2Health News:Raleigh Comprehensive and Cosmetic Dentistry Earns Certification For Sedation Dentistry 3Health News:WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance 2Health News:Hill-Rom Reports Second Quarter Financial Results 2Health News:Hill-Rom Reports Second Quarter Financial Results 3Health News:Hill-Rom Reports Second Quarter Financial Results 4Health News:Hill-Rom Reports Second Quarter Financial Results 5Health News:Hill-Rom Reports Second Quarter Financial Results 6Health News:Hill-Rom Reports Second Quarter Financial Results 7Health News:Hill-Rom Reports Second Quarter Financial Results 8Health News:Hill-Rom Reports Second Quarter Financial Results 9Health News:Hill-Rom Reports Second Quarter Financial Results 10Health News:Hill-Rom Reports Second Quarter Financial Results 11Health News:Hill-Rom Reports Second Quarter Financial Results 12Health News:Hill-Rom Reports Second Quarter Financial Results 13Health News:Hill-Rom Reports Second Quarter Financial Results 14Health News:Hill-Rom Reports Second Quarter Financial Results 15Health News:Hill-Rom Reports Second Quarter Financial Results 16Health News:Hill-Rom Reports Second Quarter Financial Results 17Health News:Hill-Rom Reports Second Quarter Financial Results 18Health News:Hill-Rom Reports Second Quarter Financial Results 19
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: